NGNE

Neurogene Stock Analysis

AI Rating

Good
  • Quality1/10
  • Growth↓ 4/10
  • Value↑ 6/10
Neurogene sales and earnings growth
NGNE Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -4.83%
  • FCF Y/Y↓ -16.77%
Neurogene gross and profit margin trends
NGNE Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -61.41%
Neurogene net debt vs free cash flow
NGNE Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -32878.3

Neurogene stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks